1. Adeniji SE, Uba S, Uzairu A (2018a) QSAR modeling and molecular docking analysis of some active compounds against Mycobacterium tuberculosis receptor (Mtb CYP121). J Pathog 2018:1018694
2. Adeniji SE, Uba S, Uzairu A (2018b) A novel QSAR model for the evaluation and prediction of (E)-N′-benzylideneisonicotinohydrazide derivatives as the potent anti-Mycobacterium tuberculosis antibodies using genetic function approach. Phys Chem Res 6:479–492
3. Adeniji SE, Uba S, Uzairu A (2018c) Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor. Future J Pharm Sci 4:284–295
4. Adeniji SE, Uba S, Uzairu A (2019) Geometrical and topological descriptors for activities modeling of some potent inhibitors against Mycobacterium Tuberculosis: a genetic functional approach. Egpt J chem 62:1635–1647
5. Eric GM, Uzairu A, Mamza PAA (2016) Quantitative structure-activity relationship (QSAR) study of the anti-tuberculosis activity of some quinolones. J Sci Res Rep 10:1–15